Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,537 | -2,085 | -1,643 | -1,742 | -1,144 |
| Depreciation Amortization | 1,043 | 1,035 | 1,024 | 811 | 564 |
| Accounts receivable | -6 | -301 | N/A | N/A | -5 |
| Other Working Capital | 58 | -198 | -199 | 126 | 276 |
| Other Operating Activity | 104 | 393 | 48 | 151 | 120 |
| Operating Cash Flow | $-1,339 | $-1,156 | $-769 | $-654 | $-190 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,850 | -1,850 | -1,850 | N/A | N/A |
| Common Stock Issued | 4,203 | 4,203 | 4,184 | 87 | 87 |
| Other Financing Activity | -162 | -162 | -162 | 0 | 0 |
| Financing Cash Flow | $2,190 | $2,190 | $2,172 | $87 | $87 |
| Beginning Cash Position | 717 | 717 | 717 | 1,284 | 1,284 |
| End Cash Position | 1,569 | 1,751 | 2,120 | 717 | 1,182 |
| Net Cash Flow | $852 | $1,034 | $1,403 | $-567 | $-103 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,339 | -1,156 | -769 | -654 | -190 |
| Free Cash Flow | -1,339 | -1,156 | -769 | -654 | -190 |